Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Oligodendroglioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00390299
What this trial is testing

Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Glioma+1 more
Mayo Clinic 23
Early research (Phase 1)Ended earlyNCT02031965
What this trial is testing

Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery

Who this might be right for
Recurrent Childhood Anaplastic AstrocytomaRecurrent Childhood Anaplastic OligoastrocytomaRecurrent Childhood Anaplastic Oligodendroglioma+4 more
Pediatric Brain Tumor Consortium 2
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Early research (Phase 1)Study completedNCT00539344
What this trial is testing

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma

Who this might be right for
Recurrent or Progressive Malignant Glioma
Angiochem Inc 63
Testing effectiveness (Phase 2)Study completedNCT00369590
What this trial is testing

VEGF Trap in Treating Patients With Recurrent Malignant Gliomas That Did Not Respond to Temozolomide

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)UnknownNCT00683761
What this trial is testing

131I-TM601 in Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+2 more
TransMolecular 64
Early research (Phase 1)Looking for participantsNCT03911388
What this trial is testing

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

Who this might be right for
Neoplasms, BrainGlioblastoma MultiformeGlioblastoma of Cerebellum+30 more
M.D. Anderson Cancer Center 24
Not applicableStudy completedNCT00499798
What this trial is testing

Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsChemotherapeutic Agent ToxicityInfertility
Wake Forest University Health Sciences 16
Early research (Phase 1)Study completedNCT00014521
What this trial is testing

Karenitecin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003467
What this trial is testing

Carmustine in Treating Adults With Recurrent Supratentorial Low-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 68
Early research (Phase 1)Study completedNCT00003765
What this trial is testing

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Ended earlyNCT00243022
What this trial is testing

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System TumorsCerebral Edema
Ali Altunkaya 12
Testing effectiveness (Phase 2)Study completedNCT00002639
What this trial is testing

Suramin in Treating Patients With Recurrent Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Emory University
Testing effectiveness (Phase 2)Looking for participantsNCT05345002
What this trial is testing

All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma

Who this might be right for
GliomaIDH MutationAstrocytoma+1 more
Stephen Bagley, MD, MSCE 55
Early research (Phase 1)Study completedNCT02015819
What this trial is testing

Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
City of Hope Medical Center 16
Early research (Phase 1)Ended earlyNCT02255461
What this trial is testing

Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Who this might be right for
Childhood Choroid Plexus TumorChildhood EpendymoblastomaChildhood Grade III Meningioma+16 more
Pediatric Brain Tumor Consortium 35
Early research (Phase 1)Study completedNCT00007813
What this trial is testing

Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Early research (Phase 1)Ended earlyNCT00572182
What this trial is testing

MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 33
Testing effectiveness (Phase 2)Study completedNCT00404248
What this trial is testing

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Ended earlyNCT01478321
What this trial is testing

Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+2 more
Northwestern University 54
Next Page